<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36842195</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-035X</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of infection and public health</Title><ISOAbbreviation>J Infect Public Health</ISOAbbreviation></Journal><ArticleTitle>Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factors.</ArticleTitle><Pagination><StartPage>596</StartPage><EndPage>602</EndPage><MedlinePgn>596-602</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jiph.2023.02.017</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1876-0341(23)00061-8</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Post acute sequelae of SARS-CoV-2 infection are defined by persistence or re-occurrence of symptoms six to 12 weeks after SARS-CoV-2 infections.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Twice vaccinated hospital employees after mild to moderate post-vaccination SARS-CoV-2 infection completed a questionnaire on the incidence of general, respiratory, neuropsychiatric, dermatological and gastrointestinal symptoms, experienced during their acute infection and eight weeks after recovery. Post acute sequelae of SARS-CoV-2 infection were analysed in relation to socio-demographic-, health-, virus- and acute infection-related characteristics.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">73 participants, 25 women and 48 men with a mean age of 40.9 years, with a post-vaccination SARS-CoV-2 infection completed the survey. Out of these 93 % reported at least one symptom at time of initial SARS-CoV-2 infection, 31.5 %, predominantly women, reported post acute sequelae at least eight weeks after the acute infection stage. Fatigue, dysgeusia and dysosmia, headache or difficulty concentrating and shortness of breath during acute infection, BMI&gt;&#xa0;25 and pre-existing pulmonary disorders were associated with post acute sequelae of SARS-CoV-2 infection. Participants with initially more than five symptoms were four times more likely to report post acute sequelae.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">It is suggested that the multiplicity of symptoms during acute SARS-CoV-2 infections increases the risk for post acute symptoms.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brunner-Ziegler</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Division of Angiology, Medical University of Vienna, Vienna, Austria. Electronic address: sophie.brunner-ziegler@meduniwien.ac.at.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xe4;uerle</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Division of Angiology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Br&#xfc;hl</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medical Directorate, Vienna General Hospital, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kornek</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Medical Directorate, Vienna General Hospital, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parschalk</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savic</LastName><ForeName>Rebeka</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Hospital Epidemiology and Infection Control, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schnetzinger</LastName><ForeName>Maximilian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Critical Care and Pain Medicine, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spath</LastName><ForeName>Tibor</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Hospital Epidemiology and Infection Control, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stra&#xdf;l</LastName><ForeName>Robert Paul</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>Division of Clinical Virology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Handisurya</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thalhammer</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Urology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Infect Public Health</MedlineTA><NlmUniqueID>101487384</NlmUniqueID><ISSNLinking>1876-0341</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001317" MajorTopicYN="N" Type="Geographic">Austria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hospital employees</Keyword><Keyword MajorTopicYN="N">Post acute sequelae of SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">Post-vaccination SARS-CoV-2 infection</Keyword></KeywordList><CoiStatement>The authors don&#xb4;t have to disclose any financial or non-financial interests that are directly or indirectly related to the work submitted for publication. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors have no competing interests to declare and no financial or personal interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>18</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36842195</ArticleId><ArticleId IdType="pmc">PMC9946725</ArticleId><ArticleId IdType="doi">10.1016/j.jiph.2023.02.017</ArticleId><ArticleId IdType="pii">S1876-0341(23)00061-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mahase E. Covid-19: vaccinated people are less likely to get long covid, review finds. BMJ. 2022;376:o407. doi: 10.1136/bmj.o407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o407</ArticleId><ArticleId IdType="pubmed">35172970</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Billig Rose E., Shapiro N.I., Files D.C., et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, MarchJune 2020. MMWR Morb Mortal Wkly Rep. 2020;69:993&#x2013;998. doi: 10.15585/MMWR.MM6930E1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/MMWR.MM6930E1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re'em Y., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38 doi: 10.1016/j.eclinm.2021.101019. Epub 2021 Jul 15. PMID: 34308300; PMCID: PMC8280690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631. doi: 10.1038/S41591-021-01292-Y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41591-021-01292-Y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. Do vaccines protect from long COVID? Lancet Respir Med. 2022;10(3):e30. doi: 10.1016/S2213&#x2013;2600(22)00020&#x2013;0. Epub 2022 Jan 20. PMID: 35065716; PMCID: PMC8776281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8776281</ArticleId><ArticleId IdType="pubmed">35065716</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization, &#x200e;2021. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. World Health Organization. https://apps.who.int/iris/handle/10665/345824. Lizenz: CC BY-NC-SA 3.0 IGO.</Citation></Reference><Reference><Citation>Weerahandi H., Hochman K.A., Simon E., Blaum C., Chodosh J., Duan E., et al. Post-discharge health status and symptoms in patients with severe COVID-19. J Gen Intern Med. 2021;36(3):738&#x2013;745. doi: 10.1007/s11606-020-06338-4. Epub 2021 Jan 14. PMID: 33443703; PMCID: PMC7808113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-020-06338-4</ArticleId><ArticleId IdType="pmc">PMC7808113</ArticleId><ArticleId IdType="pubmed">33443703</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry D.A., Jones M.A., Stehlik P., Glasziou P.P. Effectiveness of COVID-19 vaccines: findings from real world studies. Med J Aust. 2021;215(4):149&#x2013;151. 10.5694/mja2.51182. Epub 2021 Jul 22. PMID: 34296443; PMCID: PMC8447391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447391</ArticleId><ArticleId IdType="pubmed">34296443</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P., Yanay G., Zayyad H., Wertheim O., Beiruti Wiegler K., Abu Jabal K., et al. Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: a cross-sectional study of patients tested between March 2020 and November 2021. Preprint at medRxiv https://doi.org/10.1101/2022.01.05.22268800 (2022).</Citation></Reference><Reference><Citation>Antonelli M., Penfold R.S., Merino J., Sudre C.H., Molteni E., Berry S., et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6. Epub 2021 Sep 1. PMID: 34480857; PMCID: PMC8409907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428&#x2013;442. doi: 10.1177/01410768211032850. (Epub 2021 Jul 15, TLC Study Group)</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L., Cevik M., Jesudason E., Lim W.S., Rello J., Amuasi J., et al. What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol. BMJ Open. 2021;11(3) doi: 10.1136/bmjopen-2020-043887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-043887</ArticleId><ArticleId IdType="pmc">PMC7948153</ArticleId><ArticleId IdType="pubmed">33692181</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunner-Ziegler S., Spath T., Kornek G., K&#xf6;nig F., Parschalk B., Schnetzinger M., et al. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines. Clin Microbiol Infect. 2022;28(4):596&#x2013;601. doi: 10.1016/j.cmi.2021.11.023. Epub 2021 Dec 13. PMID: 34915073; PMCID: PMC8667425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.023</ArticleId><ArticleId IdType="pmc">PMC8667425</ArticleId><ArticleId IdType="pubmed">34915073</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkin A., Davison J., Tarrant R., Ross D., Halpin S., Simms A., et al. A multidisciplinary NHS COVID-19 service to manage Post-COVID-19 syndrome in the community. J Prim Care Community Health. 2021;12 doi: 10.1177/21501327211010994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501327211010994</ArticleId><ArticleId IdType="pmc">PMC8064663</ArticleId><ArticleId IdType="pubmed">33880955</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;31:372. doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Garout M.A., Saleh S.A.K., Adly H.M., Abdulkhaliq A.A., Khafagy A.A., Abdeltawab M.R., et al. Post-COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia. Infection. 2022:1&#x2013;9. doi: 10.1007/s15010-022-01788-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01788-w</ArticleId><ArticleId IdType="pmc">PMC8924350</ArticleId><ArticleId IdType="pubmed">35294728</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M., Abo Omirah M., Hussein A., Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021;75(3) doi: 10.1111/ijcp.13746. Epub 2020 Nov 3. PMID: 32991035; PMCID: PMC7536922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13746</ArticleId><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Massey D., Berrent D., Krumholz H. Preprint at medRxiv https://doi.org/10.1101/2021.07.23.21261030 (2021).</Citation></Reference><Reference><Citation>Taquet M., Dercon Q., Harrison P.J. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun. 2022;103:154&#x2013;162. doi: 10.1016/j.bbi.2022.04.013. Epub 2022 Apr 18. PMID: 35447302; PMCID: PMC9013695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., De Rose C., Sinatti D., Ricchiuto A., Carf A., et al. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110:2208&#x2013;2211. doi: 10.1111/APA.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/APA.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayaaslan B., Eser F., Kalem A.K., Kaya G., Kaplan B., Kacar D., et al. Post-COVID syndrome: a single-center questionnaire study on 1007 participants recovered from COVID-19. J Med Virol. 2021;93:6566&#x2013;6574. doi: 10.1002/JMV.27198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JMV.27198</ArticleId><ArticleId IdType="pmc">PMC8426910</ArticleId><ArticleId IdType="pubmed">34255355</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D., Ballouz T., Anagnostopoulos A., Aschmann H.E., Domenghino A., Fehr J.S., et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: a population-based cohort study. PLOS One. 2021;16(7) doi: 10.1371/journal.pone.0254523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254523</ArticleId><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>Barda N., Dagan N., Cohen C., Hern&#xe1;n M.A., Lipsitch M., Kohane I.S., et al. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet. 2021;398(10316):2093&#x2013;2100. doi: 10.1016/S0140-6736(21)02249-2. PMID: 34756184; PMCID: PMC8555967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02249-2</ArticleId><ArticleId IdType="pmc">PMC8555967</ArticleId><ArticleId IdType="pubmed">34756184</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C., et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):3528. doi: 10.1038/s41467-022-30836-0. PMID: 35764621; PMCID: PMC9240035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelrahman M.M., Abd-Elrahman N.M., Bakheet T.M. Persistence of symptoms after improvement of acute COVID19 infection, a longitudinal study. J Med Virol. 2021;93:5942&#x2013;5946. doi: 10.1002/JMV.27156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JMV.27156</ArticleId><ArticleId IdType="pmc">PMC8426945</ArticleId><ArticleId IdType="pubmed">34171139</ArticleId></ArticleIdList></Reference><Reference><Citation>Norton A., Olliaro P., Sigfrid L., Carson G., Paparella G., Hastie C., et al. Long COVID: tackling a multifaceted condition requires a multidisciplinary approach. Lancet Infect Dis. 2021;21:601&#x2013;602. doi: 10.1016/S1473-3099(21)00043-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00043-8</ArticleId><ArticleId IdType="pmc">PMC7906694</ArticleId><ArticleId IdType="pubmed">33548193</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V., Flanders S.A., O&#x2019;Malley M., Malani A.N., Prescott H.C. Sixty-day outcomes among patients hospitalized with COVID19. Ann Intern Med. 2021;174:576&#x2013;578. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain N., Agarwala P., Iqbal K., Omar H.M.S., Jangid G., Patel V., et al. A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation. J Med Virol. 2022;94(4):1391&#x2013;1401. doi: 10.1002/jmv.27534. Epub 2021 Dec 28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27534</ArticleId><ArticleId IdType="pubmed">34931698</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Health Security Agency. The effectiveness of vaccination against long covid: a rapid evidence briefing. Feb 2022. https://ukhsa.koha-ptfs.co.uk/cgi-bin/koha/opac-retrieve-file.pl?id=fe4f10cd3cd509fe045ad4f72ae0dfff</Citation></Reference><Reference><Citation>Malik P., Patel K., Pinto C., Jaiswal R., Tirupathi R., Pillai S., et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL) &#x2013; a systematic review and meta-analysis. J Med Virol. 2022;94:253&#x2013;262. doi: 10.1002/jmv.27309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>